Since 2021, FormularyDecisions has partnered with managed care experts at UMass Chan Medical School to develop curated pre-approval information, clinical trial summaries, and P&T considerations through Product Snapshots (available exclusively on FormularyDecisions). We offer over 400 product snapshots, and are adding more product information all the time.

Complete the form to download a product snapshot today for Giroctocogene Fitelparvovec, a gene therapy under investigation for Hemophilia A.

_{Note: FormularyDecisions is not providing product recommendations. Readers should review all available materials related to the products and indications before making any decision related to the purchase or use of the products.}